Annual report pursuant to Section 13 and 15(d)

INTELLECTUAL PROPERTY/ LICENSING RIGHTS (Details Narrative)

v3.3.1.900
INTELLECTUAL PROPERTY/ LICENSING RIGHTS (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Amortization $ 66,176 $ 132,353
Naltrexone Implant Formulation [Member]    
Amortization $ 56,600